Immunohistochemical staining of ELOVL5 in a series of 263 CRC tissues showed clear differences in protein levels between tumors, but we found no evidence for ELOVL5 protein level differences being associated with tumor stage or relapse free survival. Here, ELOVL5 is linked to colorectal carcinoma.